ORKAMBI is a prescription medicine used for the treatment of cystic fibrosis (CF) in patients age
ORKAMBI should not be used in patients other than those who have two copies of the F508del mutation in their CFTR gene.
It is not known if ORKAMBI is safe and effective in children under 6 years of age.
ORKAMBI is a breakthrough treatment for the underlying cause of
Watch ORKAMBI in action
Watch a video to learn about ORKAMBI, CFTR proteins, and the F508del mutation.